论文部分内容阅读
Since the advent of direct acting antiviral(DAA)agents,chronic hepatitis C virus(HCV)treatment has evolved at a rapid pace.In contrast to prior regimen involving ribavirin and pegylated interferon,these newer agents are highly effective,well-tolerated,hav